Shattuck Labs STTK
NASDAQ STTK
$6.73 +0.19 (+2.91%)
As of: Sep 30, 2026 · 9:35 AM EDT

Shattuck Labs (STTK) Current Deferred Revenue (2019 - 2024)

Updated

Shattuck Labs (STTK) recorded Current Deferred Revenue of $3 million in Q2 2024, down 34.9% from the prior quarter.

Analysis

Shattuck Labs (STTK) Current Deferred Revenue (2019 - 2024) Analysis & Trends

At the end of FY2023, Shattuck Labs reported Current Deferred Revenue of $343,000.

  • Annual Current Deferred Revenue has a four-year compound annual growth rate of -59.6% (FY2019 to FY2023).
  • Across earlier years, Current Deferred Revenue came in at $7.73 million in FY2020 (-40.1%) and $12.89 million in FY2019.
  • Quarterly Current Deferred Revenue has ranged from $343,000 in Q4 2023 to $12.89 million in Q4 2019 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Shattuck Labs 834.48 Mn 834.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.00 Mn
Mar 31, 2024 4.61 Mn
Dec 31, 2023 343,000.00
Sep 30, 2021 2.80 Mn
Jun 30, 2021 2.78 Mn
Mar 31, 2021 9.66 Mn
Dec 31, 2020 7.73 Mn
Sep 30, 2020 8.61 Mn
Dec 31, 2019 12.89 Mn
API Access

Shattuck Labs Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=STTK&period=max&api_key=YOUR_API_KEY